NuSirt announces $6 million Series C funding round

NuSirt BiopharmaGood news for NuSirt Biopharma, Inc., a company founded by Knoxvillian Michael Zemel. Now headquartered in Nashville with Zemel still based in Knoxville at the Fairview Technology Center, NuSirt announced yesterday that it has raised a $6 million Series C round of investment capital with $2 million funded.

According to the release, Hatteras Venture Partners was joined by existing stockholders that include Mountain Group Partners and TriStar Technology Ventures.

NuSirt is focused on improving the lives of those with chronic metabolic diseases such as diabetes.

We profiled the journey of Zemel, a former University of Tennessee Professor, in a multi-part series earlier this year (Part 1, Part 2, and Part 3).

Tom Ballard

By Tom Ballard, Chief Alliance Officer,
Pershing Yoakley & Associates. P.C.

eNews & Updates

Sign up to receive posts via email.

Connect With Us

Upcoming Events

Links to Partners